CLSI M52 (R2020)

Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, M52Ed1E

Clinical and Laboratory Standards Institute, 08/01/2015

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:01/08/2015

Pages:92

File Size:1 file , 2.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline includes recommendations for verification of commercial US Food and Drug Administration?cleared microbial identification and antimicrobial susceptibility testing systems by clinical laboratory professionals to fulfill regulatory or quality assurance requirements for the use of these systems for diagnostic testing.

More CLSI standard pdf

CLSI C40-A

Analytical Procedures for the Determination of Lead in Blood and Urine; Approved Guideline, C40AE

$141.00 $282.79

CLSI C31-A2

Ionized Calcium Determinations: Precollection Variables, Specimen Choice, Collection, and Handling; Approved Guideline, C31A2E

$100.00 $201.32

CLSI M23A2

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2

$109.00 $219.97

CLSI AUTO04-A

Laboratory Automation: Systems Operational Requirements, Characteristics, and Information Elements; Approved Standard, AUTO04AE

$107.00 $214.51